-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

Increasing Awareness of Risk Factors for AL Amyloidosis

Program: Special-Interest Sessions
Session: ASH Clinical Practice Guidelines on Amyloidosis
Hematology Disease Topics & Pathways:
Acute Myeloid Malignancies, AML, Clinical Practice (Health Services and Quality), Diseases, Myeloid Malignancies
Sunday, December 8, 2024, 4:30 PM-6:00 PM

Joselle Cook, MBBS

Mayo, Rochester, MN

Disclosures: Cook: Geron Corp: Other: Held $600 Geron Stock for one week and sold without profit .

See more of: ASH Clinical Practice Guidelines on Amyloidosis
See more of: Special-Interest Sessions
Previous Presentation | Next Presentation >>